Stenocare A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STENO.CO research report →
About the company
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
- CEO
- Thomas Skovlund Schnegelsberg
- IPO
- 2020
- Employees
- 4
- HQ
- Randers, DC, DK
Price Chart
- Market Cap
- $45.14M
- P/E
- -50.73
- P/S
- 4.88
- P/B
- 5.01
- EV/EBITDA
- 272.33
- Div Yield
- 0.00%
- Gross Margin
- 2.97%
- Op Margin
- -3.25%
- Net Margin
- -9.25%
- ROE
- -14.90%
- ROIC
- -2.85%
- Revenue
- $7.02M · 214.54%
- Net Income
- $-2,390,440 · 93.07%
- EPS
- $-0.06 · 94.47%
- Op Income
- $-1,773,664
- FCF YoY
- -0.37%
- 52W High
- $2.80
- 52W Low
- $0.40
- 50D MA
- $1.11
- 200D MA
- $1.35
- Beta
- 0.48
- Avg Volume
- 171.81K
Get TickerSpark's AI analysis on STENO.CO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our STENO.CO coverage
Recent articles, reports, and earnings notes.
No research on STENO.CO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate STENO.CO report →Similar companies
Peers in the same neighborhood.